<DOC>
	<DOCNO>NCT00700518</DOCNO>
	<brief_summary>The purpose study evaluate blood flow response topical Glyceryl Trinitrate apply skin patient 's finger Raynaud 's Phenomenon .</brief_summary>
	<brief_title>Dose Response Topical Glyceryl Trinitrate Patients With Raynaud 's Phenomenon</brief_title>
	<detailed_description />
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Male female volunteer age 18 50 inclusive Subject idiopathic RP ( patient may undifferentiated connective tissue disease positive ANA ) diagnose two ( 2 ) year If female , subject must nonpregnant nonlactating The subject provide write informed consent prior admission study History clinically relevant medical illness ( consider RP ) Investigator 's opinion may jeopardize subject 's safety interfere participation study , include limited hemoglobinopathy , hemophilia , clinically significant retinal abnormality , unstable hypertension , liver disease , chronic pulmonary disease , significant cardiovascular disease , diabetes , thyroid disease , gout , psychiatric psychological disorder , CNS trauma active seizure disorder , allergic immunologically mediated disorder History past five ( 5 ) year drug alcohol abuse History past five ( 5 ) year vascular migraine chronic severe headache History past five ( 5 ) year autonomic neuropathy postural hypotension Unwilling unable comply restriction outline protocol Current use smoking cessation treatment , include nicotine patch History drug allergy , anaphylaxis laryngeal oedema , include allergy GTN , propylene/ethylene glycol common moisturize cream Use nitrate medication phosphodiesterase inhibitor within three ( 3 ) day prior intend use one ( 1 ) day follow dose study drug Currently treat hypertension Currently receive treatment prevention and/or treatment RP Use investigational medication within 30 day prior dose study medication schedule receive investigational drug course study Open skin lesion pathological condition ( include , limited , infection ) area study medication apply Use topical corticosteroid hand finger within 10 day treatment study drug Withdrawal consent time study Any condition , compromise ability give inform consent communicate investigator require completion study Previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Raynaud 's Syndrome</keyword>
	<keyword>Raynaud 's Disease</keyword>
	<keyword>RP</keyword>
</DOC>